Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ed T Buurman

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Journal of Bacteriology|June 19, 2004
Multiple paths for nonphysiological transport of K+ in Escherichia coliEd T Buurman, Debbie McLaggan, Josef Naprstek, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2003
Pyridines and pyrimidines mediating activity against an efflux-negative strain of Candida albicans through putative inhibition of lanosterol demethylaseEd T Buurman, April E Blodgett, Kenneth G Hull, et al.
Antimicrobial Agents and Chemotherapy|December 27, 2005
Different modes of action of naphthyridones in gram-positive and gram-negative bacteriaEd T Buurman, Kenneth D Johnson, Roxanne K Kelly, et al.
Journal of Medicinal Chemistry|January 10, 2012
Molecular determinants of AcrB-mediated bacterial efflux implications for drug discoveryJohn I Manchester, Ed T Buurman, Gregory S Bisacchi, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Antimicrobial Activity of Adenine-Based Inhibitors of NAD(+)-Dependent DNA LigaseEd T Buurman, Valerie A Laganas, Ce Feng Liu, et al.
G3 (Bethesda, Md.)|October 7, 2015
Markerless Escherichia coli rrn Deletion Strains for Genetic Determination of Ribosomal Binding SitesSelwyn Quan, Ole Skovgaard, Robert E McLaughlin, et al.
Mbio|March 10, 2016
Staphylococcus aureus Clumping Factor A Remains a Viable Vaccine Target for Prevention of S. aureus InfectionAnnaliesa S Anderson, Ingrid L Scully, Ed T Buurman, et al.
Antimicrobial Agents and Chemotherapy|May 27, 2005
Utilization of target-specific, hypersensitive strains of Saccharomyces cerevisiae to determine the mode of action of antifungal compoundsEd T Buurman, Beth Andrews, April E Blodgett, et al.
Archives of Microbiology|November 7, 2002
Validation of Cdc68p as a novel antifungal targetEd T Buurman, Weidong Jiang, Melissa McCoy, et al.
ACS Infectious Diseases|August 4, 2021
The CARB-X Portfolio of Nontraditional Antibacterial ProductsErin M Duffy, Ed T Buurman, Su L Chiang, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Journal of Bacteriology|June 19, 2004
Multiple paths for nonphysiological transport of K+ in Escherichia coliEd T Buurman, Debbie McLaggan, Josef Naprstek, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2003
Pyridines and pyrimidines mediating activity against an efflux-negative strain of Candida albicans through putative inhibition of lanosterol demethylaseEd T Buurman, April E Blodgett, Kenneth G Hull, et al.
Antimicrobial Agents and Chemotherapy|December 27, 2005
Different modes of action of naphthyridones in gram-positive and gram-negative bacteriaEd T Buurman, Kenneth D Johnson, Roxanne K Kelly, et al.
Journal of Medicinal Chemistry|January 10, 2012
Molecular determinants of AcrB-mediated bacterial efflux implications for drug discoveryJohn I Manchester, Ed T Buurman, Gregory S Bisacchi, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Antimicrobial Activity of Adenine-Based Inhibitors of NAD(+)-Dependent DNA LigaseEd T Buurman, Valerie A Laganas, Ce Feng Liu, et al.
G3 (Bethesda, Md.)|October 7, 2015
Markerless Escherichia coli rrn Deletion Strains for Genetic Determination of Ribosomal Binding SitesSelwyn Quan, Ole Skovgaard, Robert E McLaughlin, et al.
Mbio|March 10, 2016
Staphylococcus aureus Clumping Factor A Remains a Viable Vaccine Target for Prevention of S. aureus InfectionAnnaliesa S Anderson, Ingrid L Scully, Ed T Buurman, et al.
Antimicrobial Agents and Chemotherapy|May 27, 2005
Utilization of target-specific, hypersensitive strains of Saccharomyces cerevisiae to determine the mode of action of antifungal compoundsEd T Buurman, Beth Andrews, April E Blodgett, et al.
Archives of Microbiology|November 7, 2002
Validation of Cdc68p as a novel antifungal targetEd T Buurman, Weidong Jiang, Melissa McCoy, et al.
ACS Infectious Diseases|August 4, 2021
The CARB-X Portfolio of Nontraditional Antibacterial ProductsErin M Duffy, Ed T Buurman, Su L Chiang, et al.
Pageof 4